InvestorsHub Logo
Followers 29
Posts 2651
Boards Moderated 0
Alias Born 07/26/2016

Re: Empiricst1 post# 271403

Sunday, 08/25/2019 10:01:33 AM

Sunday, August 25, 2019 10:01:33 AM

Post# of 403306
Bottom line, on just 3 cases and lots of pre-clinical kevetrin looks to be well tolerated w/o the huge and damaging side effects that chemo/rad treatments as well as the newer bioligcs can cause. And kevetrin may be potent in a number of different cancers; may, as noted. So that's why I would look at it as well as may other options in pancreatic cancer. On the other hand IPIX may just be too small, flying way under the radar for any big institution or specialist to even have its minor flagship drug even noticed. And it's at that small space that I would enter the fray if it were one of mine involved. And probably achieve nothing, but not for lack of trying.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News